Inmune Bio (INMB) stock skyrocketed to a record high Tuesday after the biotech company unveiled promising results for its Alzheimer’s treatment. Researchers tested the Alzheimer’s treatment in six patients over 12 weeks. At a lower dose, patients showed a 1.7% increase in brain inflammation. Patients who received a higher dose showed a 2.3% decrease. That compares with […]

The Business Of Biotech “Summer Executive Sessions” kick off with a candid conversation with Athersys CFO Ivor Macleod, who brings years of finance leadership at Roche, Merck, and other big pharmas to Athersys as the company readies its lead candidate for life beyond clinical trials. Join us for a discussion on how Macleod is applying […]

China, a global hotspot for liver and digestive system diseases, has emerged as an attractive target market for developers of genomic liver and colon cancer screening tests, with the potential to generate billions of dollars of annual revenue. California-based Helio – formerly the Laboratory for Advanced Medicine – will soon apply for approval in China […]